Skip to main content

Clinical Trials › NCT05090371

Active, Not RecruitingPhase 4

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Sponsored by Novartis Pharmaceuticals

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
136
Target enrollment
19
U.S. states
Mar 2022
Start date
Apr 2027
Expected completion

Interventions / Treatments

OfatumumabDisease modifying treatment (DMT)

Conditions studied

Relapsing-Remitting Multiple Sclerosis

Where this trial is running (37 sites)

Florida7 sites
Altamonte Springs · Cape Coral · Homestead · +4 more
Texas5 sites
Houston · Katy · Lubbock · +2 more
Chapel Hill · Charlotte · Raleigh
Alabama2 sites
Birmingham · Cullman
Arizona2 sites
Chandler · Phoenix
Michigan2 sites
Detroit · Owosso
New Jersey2 sites
Livingston · Neptune City
Washington2 sites
Kirkland · Seattle
Wisconsin2 sites
Green Bay · Milwaukee
Torrance
Idaho1 site
Coeur d'Alene
Louisiana1 site
Alexandria
Maryland1 site
Lutherville
Worcester
Jackson
New York1 site
Syracuse
Summerville
Tennessee1 site
Knoxville
Virginia1 site
Virginia Beach

MS centers in Florida

Compare treatment centers near a trial site by center type, providers and trials.

View Florida centers

More Phase 4 trials

Browse all Phase 4 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play